Today, the New Jersey legislature passed the state’s operating budget. Included in that budget was an increase of $1.5 million in funding for the New Jersey Cancer Education and Early Detection (NJCEED) program for a total of $5 million.
As a nonprofit entity whose mission is improving the lives of people with cancer and their families, the American Cancer Society isn’t taking sides on the decision. However, the decision will impact cancer patients and their families and is likely to disproportionately effect communities of color.
Michigan legislature passed a package of bills they say will help reduce Big Tobacco’s grip on Michigan, but these bills are a wolf in sheep’s clothing.
The majority of Imperial residents know that secondhand smoke is harmful and support smoke-free policies that protect their families, friends and neighbors. A new billboard campaign aims to prompt city leaders into action with a strong message: Secondhand smoke doesn’t belong here.
Las principales organizaciones del país de todo el espectro de la atención médica están instando al Congreso a extender los créditos fiscales ampliados de la prima de atención médica de la Ley del Cuidado de Salud a Bajo Precio (ACA, siglas en inglés).
Today the U.S. Food and Drug Administration (FDA) announced it will issue marketing denial orders to all JUUL e-cigarette products.
RALEIGH, NC – June 22, 2022 – A new series of advertisements paid for by the American Cancer Society Cancer Action Network (ACS CAN) that launched last week will be paused following recent progress in the Ho
Today the Biden Administration announced its intention for the U.S. Food and Drug Administration (FDA) to put forth a proposed rule to set a maximum level of nicotine in cigarettes and certain tobacco products to an amount that would reduce addiction.
RALEIGH, NC – June 21, 2022 – A new series of advertisements paid for by the American Cancer Society Cancer Action Network (ACS CAN) launched yesterday citing the impact Medicaid expansion can have on the health of North Car
The California Assembly Health Committee passed a bill today that would ensure comprehensive biomarker testing is covered by more insurance plans, including Medi-Cal, when supported by medical and scientific evidence.